Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In CNS/Brain Cancer CNS/Brain Cancer for January/February 2020 Late effects in young cancer survivors underscore importance of high-risk screening, Glioma trials should track living well, not just longer, Global project reveals cancer’s genomic playbook, QoL Good for MGMT-Methylated Glioblastoma Patients With Lomustine-Temozolide, More must reads CNS/Brain Cancer for November/December 2019 IORT boosts local control, survival of glioblastoma, More must readsCNS/Brain Cancer for September/October 2019 BRCA Mutations Confer High Risk of CNS Metastases, HER2-mutant NSCLC Confers High Brain Metastases Risk, Tandem Transplants Provide EFS Edge in Pediatric Neuroblastoma, More must readsCNS/Brain Cancer for July/August 2019 Clinicians Should Screen Glioma Patients Preoperatively for Depression, Researchers Target Brain Metastases in NSCLC, EHR Default Order Reduces Unnecessary Imaging During Palliative RT, More must readsCNS/Brain Cancer for May/June 2019 Trial matches pediatric cancer patients to targeted therapies, Entrectinib exhibits activity in children with solid tumors, More must readsPages« first 1 2 3 4 last »
